Filing Details

Accession Number:
0001237899-20-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-31 16:36:38
Reporting Period:
2020-08-31
Accepted Time:
2020-08-31 16:36:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225471 L George Sing 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-31 3,600 $610.45 60,815 No 4 S Direct
Common Stock Disposition 2020-08-31 1,400 $611.38 59,415 No 4 S Direct
Common Stock Disposition 2020-08-31 2,000 $612.27 57,415 No 4 S Direct
Common Stock Disposition 2020-08-31 1,100 $613.54 56,315 No 4 S Direct
Common Stock Disposition 2020-08-31 1,900 $614.51 54,415 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,150 Indirect by Spouse
Common Stock 400 Indirect by Spouse/Cust Son
Common Stock 3,700 Indirect by Trust for Son
Footnotes
  1. Represents volume-weighted average price of sales of 3,600 shares of Company stock on August 31, 2020 at prices ranging from $610.05 to $610.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
  2. Represents volume-weighted average price of sales of 1,400 shares of Company stock on August 31, 2020 at prices ranging from $611.13 to $611.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 2,000 shares of Company stock on August 31, 2020 at prices ranging from $612.05 to $612.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 1,100 shares of Company stock on August 31, 2020 at prices ranging from $613.00 to $613.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 31, 2020 at prices ranging from $614.01 to $614.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.